Pouliot, F. (2026) “Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian center”, Canadian Urological Association Journal, 20(6). doi: 10.5489/cuaj.9398.